Northwire Canada EditionTuesday, August 25, 2026
Northwire
GOLD 4697.80 +0.4% SILVER 68.59 −1.4% COPPER 6.61 +0.3% OIL 85.01 −2.4% PALLADIUM 1359.75 +0.7% NVO 0.070 +0.0% SRA 0.780 +0.0% TUK 0.020 −20.0% GWM 0.610 −4.7% MINE 0.110 +0.0% EGM 0.100 +0.0% IRO 1.11 +2.8% CBR 1.41 +2.5% CTN 0.045 +0.0% GMX 2.06 +2.0% NPR 0.700 −2.8% CGD 1.28 +8.5% CRE 0.390 +13.0% PE 0.250 +0.0% PER 0.150 +7.1% SVRS 0.540 +8.0% GOLD 4697.80 +0.4% SILVER 68.59 −1.4% COPPER 6.61 +0.3% OIL 85.01 −2.4% PALLADIUM 1359.75 +0.7% NVO 0.070 +0.0% SRA 0.780 +0.0% TUK 0.020 −20.0% GWM 0.610 −4.7% MINE 0.110 +0.0% EGM 0.100 +0.0% IRO 1.11 +2.8% CBR 1.41 +2.5% CTN 0.045 +0.0% GMX 2.06 +2.0% NPR 0.700 −2.8% CGD 1.28 +8.5% CRE 0.390 +13.0% PE 0.250 +0.0% PER 0.150 +7.1% SVRS 0.540 +8.0%
M&A / Property Routine +

Gstaad Capital closes QT, changes name to Illumisoft

Shell company completes reverse takeover with germicidal UV product

Executive Summary
  • Illumisoft Lighting Corp., formerly Gstaad Capital Corp., has completed a qualifying transaction (QT) via amalgamation with Claranova Technologies Inc.
  • The company is now listed on the TSX Venture Exchange under ticker symbol UVC, trading anticipated to begin April 23, 2026.
  • A share consolidation occurred at a ratio of 0.2 post-consolidated shares for every pre-consolidation common share.
  • Claranova Technologies Inc. is now a wholly owned subsidiary; Illumisoft acquired all of Claranova's assets.
  • Subscription receipts previously issued at $0.30 (gross proceeds $6,441,975) were exchanged for post-consolidation shares.
  • A debenture was issued in exchange for Claranova’s outstanding debt ($333,333 principal), repayable on May 4, 2026.
  • New equity incentives include 3,540,000 stock options and 425,390 share purchase warrants, all exercisable at $0.30 per post-consolidation common share.
  • Auditor changed from Crowe MacKay LLP to Kenway Mack Slusarchuk Stewart LLP.
Material Impact
  • The completion of the QT is a standard milestone for shell companies that have previously announced their intent and raised capital (subscription receipts were "previously issued").
  • The news confirms the transition from a shell entity to an operating company with a Health Canada-registered product, which validates the business model but does not introduce new unexpected upside.
  • The immediate debt maturity of $333,333 due May 4, 2026 (13 days post-news) creates significant near-term liquidity pressure for a newly listed entity.
  • Dilution is substantial with over 3.9 million warrants/options issued at the current strike price ($0.30), capping immediate upside if exercised or sold by insiders.
  • The rating reflects that while the listing and capital raise are positive, they were largely anticipated given the prior issuance of subscription receipts; thus, it is routine rather than a game changer.
UVC · Price
Company Overview
  • Company: Illumisoft Lighting Corp. (formerly Gstaad Capital Corp.).
  • Flagship Project: Health Canada-registered upper-room germicidal ultraviolet air disinfection product.
  • Business Model: Commercial lighting business combined with UV air disinfection technology.
  • Development Status: Product preparing to enter active commercial use; assets acquired via QT from Claranova Technologies Inc.
Read the original news release →

More from Illumisoft Lighting Corp